|
PAFAH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.517300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.454440E-02 |
| Normal-vs-Stage2 |
2.482000E-01 |
| Normal-vs-Stage3 |
2.359500E-04 |
| Normal-vs-Stage4 |
2.438400E-04 |
| Stage1-vs-Stage2 |
9.742200E-03 |
| Stage1-vs-Stage3 |
2.953900E-02 |
| Stage1-vs-Stage4 |
3.650100E-02 |
| Stage2-vs-Stage3 |
4.215900E-04 |
| Stage2-vs-Stage4 |
4.224700E-04 |
| Stage3-vs-Stage4 |
7.556000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.369900E-04 |
| Normal-vs-AfricanAmerican |
1.785440E-01 |
| Normal-vs-Asian |
1.640960E-03 |
| Caucasian-vs-AfricanAmerican |
5.940800E-01 |
| Caucasian-vs-Asian |
4.473800E-01 |
| AfricanAmerican-vs-Asian |
3.373200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.975900E-03 |
| Normal-vs-Female |
1.171770E-02 |
| Male-vs-Female |
3.651000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.738000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.403400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.348000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.769600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.388000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.084800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.754000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.106500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.976600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.292000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.342000E-03 |
| Classical-VS-Follicular |
7.58710000381413E-08 |
| Classical-VS-Other |
4.504400E-01 |
| Classical-VS-Normal |
4.447000E-04 |
| Tall-VS-Follicular |
5.8690052817667E-11 |
| Tall-VS-Other |
5.577600E-01 |
| Tall-VS-Normal |
1.54400000007548E-07 |
| Follicular-VS-Other |
6.12509999999844E-05 |
| Follicular-VS-Normal |
1.842070E-02 |
| Other-VS-Normal |
1.126020E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.338000E-01 |
| Normal-vs-N1 |
2.22119999948589E-07 |
| N0-vs-N1 |
1.92060000003824E-06 |
|
|
